Volume 24, Number 2—February 2018
CME ACTIVITY - Research
Clinical and Molecular Epidemiology of Staphylococcal Toxic Shock Syndrome in the United Kingdom
Hema Sharma, Debra Smith, Claire E. Turner1, Laurence Game, Bruno Pichon, Russell Hope, Robert Hill, Angela Kearns2, and Shiranee Sriskandan2
Table 1
Clinical characteristics of staphylococcal toxic shock syndrome cases, United Kingdom, 2008–2012*
| Characteristics | All patients, n = 180† | Menstrual, n = 70 | Nonmenstrual, n = 107 | p value |
|---|---|---|---|---|
| Median age, y (IQR) |
19.0 (9.0–38.3) |
21.5 (17–35.3) |
15.0 (1–43.5) |
0.01‡ |
| Sex, no. (%) | ||||
| F | 128 (71.1) | 70 (100) | 55 (51.4) | 0.0001§ |
| M | 51 (28.3) | 0 | 51 (47.7) | |
| Unknown |
0 |
0 |
1 (0.9) |
|
| Deaths, no. (%) | 9 (5.0) | 4 (5.7) | 5 (4.7) | 0.74§ |
*Boldface indicates a statistically significant result, p<0.05. IQR, interquartile range.
†3 patient isolates not assigned as menstrual or nonmenstrual due to lack of clinical data
‡Mann-Whitney U test comparing menstrual and nonmenstrual TSS cases.
§Fisher exact test comparing menstrual and nonmenstrual TSS cases.
1Current affiliation: University of Sheffield, Sheffield, UK.
2These authors contributed equally to this article.
Page created: January 11, 2018
Page updated: January 11, 2018
Page reviewed: January 11, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.